Licensed subcutaneous infusion therapies in advanced Parkinson’s disease: an indirect treatment comparison and cost-minimisation analysis
Version 2 2025-07-10, 07:37Version 2 2025-07-10, 07:37
Version 1 2025-06-16, 10:33Version 1 2025-06-16, 10:33
media
posted on 2025-07-10, 07:37authored byAdis journals on behalf of:, Marc Vérin, Ángel Sesar, Bharat Amlani, Smith, Niall, Konstantinos Kipentzoglou, Stephen Montgomery, Alice Reading, Andrei Karlsson, Anna Willis, Andrew J. Lees
<p dir="ltr">There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).</p>